Literature DB >> 11424951

Neuroprotective activities of estrogen: an update.

C Behl1, D Manthey.   

Abstract

For many molecules, which have been found first in a certain tissue and with a certain activity in the body, multiple activities have been discovered decades later. The steroidal compound estrogen (estradiol) is certainly such a molecule. What was first described as the female sex hormone is now well acknowledged as a central neuroactive and neuromodulatory molecule. One important aspect of estrogen's effects on neurons is its neuroprotective activity. Cellular and molecular studies underline powerful neuroprotective functions of estrogen which are characterized by long-term "classical" genomic effects as well as by rapid activities depending on estrogens interaction with neuronal membranes and intracellular signal transduction pathways. In addition, estrogen has been shown to bear an intrinsic antioxidant structure that lies in the phenolic moiety of the steroidal compound. This antioxidant activity of estrogen and estrogen-derivatives may provide an antioxidant "chemical shield" for neurons and may complement other neuroprotective activities of estrogen and therefore also mediate some of the beneficial effects of estrogen replacement with respect to Alzheimer's Disease. Although, investigated for decades estrogen and its receptors may still hold many surprises that remain to be identified. With the advent of novel genomic techniques, the neuronal target genes of estrogen will be identified in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11424951     DOI: 10.1023/a:1007109222673

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  27 in total

Review 1.  Cellular strategies of estrogen-mediated neuroprotection during brain development.

Authors:  Malgorzata Kajta; Cordian Beyer
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 2.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

3.  Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.

Authors:  Fabio Di Domenico; Gabriella Casalena; Rukhsana Sultana; Jian Cai; William M Pierce; Marzia Perluigi; Chiara Cini; Alessandra Baracca; Giancarlo Solaini; Giorgio Lenaz; Jia Jia; Suzan Dziennis; Stephanie J Murphy; Nabil J Alkayed; D Allan Butterfield
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

4.  Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Kerstin Genz; Ellen Reith; Dana Pospischil; Suresh Govindarajalu; Mark Dzietko; Stefanie Pesditschek; Ingrid Mai; Krikor Dikranian; John W Olney; Chrysanthy Ikonomidou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  Thiophene-core estrogen receptor ligands having superagonist activity.

Authors:  Jian Min; Pengcheng Wang; Sathish Srinivasan; Jerome C Nwachukwu; Pu Guo; Minjian Huang; Kathryn E Carlson; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2013-04-15       Impact factor: 7.446

6.  Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia.

Authors:  Amanda Sierra; Iñigo Azcoitia; Luis Garcia-Segura
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

7.  Effects of estradiol, phytoestrogens, and Ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress.

Authors:  Benoit Gagné; Sylvie Gélinas; Geneviève Bureau; Bruno Lagacé; Charles Ramassamy; Keith Chiasson; Barbara Valastro; Maria-Grazia Martinoli
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

Review 8.  Mechanisms of gender-linked ischemic brain injury.

Authors:  Mingyue Liu; Suzan Dziennis; Patricia D Hurn; Nabil J Alkayed
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

Review 9.  Sex, sex steroids, and brain injury.

Authors:  Paco S Herson; Ines P Koerner; Patricia D Hurn
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

10.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.